Vivos Therapeutics News

Express News | Vivos Therapeutics Disclosed The Closing Of $7.5M At-The-Market Private Equity-Backed Investment And Launch Of Strategic Marketing And Distribution Alliance

BenzingaJun 12 07:38 ET

Express News | Vivos Therapeutics Closes $7.5 Million at-the-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

ReutersJun 12 07:30 ET

Vivos Therapeutics Announces Strategic Alliance and $7.5M Investment | NASDAQ:VVOS

Proactive InvestorsJun 12 04:59 ET

Earnings Call Summary | Vivos Therapeutics(VVOS.US) Q1 2024 Earnings Conference

The following is a summary of the Vivos Therapeutics, Inc. (VVOS) Q1 2024 Earnings Call Transcript:Financial Performance:Vivos Therapeutics reported Q1 2024 total revenue of $3.4 million, a decrease c

moomoo AIMay 18 09:10 ET · Conference Call

Vivos Therapeutics, Inc. (VVOS) Q1 2024 Earnings Call Transcript

Vivos Therapeutics, Inc. (VVOS) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 17 21:02 ET

Vivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Yahoo FinanceMay 15 13:01 ET

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

GainersSINTX Techs (NASDAQ:SINT) stock moved upwards by 143.1% to $0.13 during Wednesday's pre-market session. The company's market cap stands at $16.4 million. The company's, Q1 earnings came out 2 d

BenzingaMay 15 08:06 ET

Express News | Vivos Therapeutics Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q1 Sales Results

BenzingaMay 14 17:05 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersArcutis Biotherapeutics (NASDAQ:ARQT) stock moved upwards by 16.4% to $9.46 during Tuesday's after-market session. The company's market cap stands at $1.0 billion. As per the press release, Q1

BenzingaMay 14 16:31 ET

Vivos Therapeutics | 10-Q: Quarterly report

SEC announcementMay 14 16:22 ET · Announcements

Express News | Vivos Therapeutics Q1 EPS $(1.63) Up From $(1.72) YoY, Sales $3.42M Down From $3.86M YoY

BenzingaMay 14 16:10 ET

Earnings Flash (VVOS) VIVOS THERAPEUTICS Reports Q1 Revenue $3.4M

04:10 PM EDT, 05/14/2024 (MT Newswires) -- Earnings Flash (VVOS) VIVOS THERAPEUTICS Reports Q1 Revenue $3.4M

MT NewswiresMay 14 16:10 ET

Express News | Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

ReutersMay 14 16:05 ET

Express News | Vivos Therapeutics Q1 Operating Expenses USD 5.722 Million

ReutersMay 14 16:05 ET

Express News | Vivos Therapeutics Q1 Operating Income USD -3.785 Million

ReutersMay 14 16:05 ET

Vivos Therapeutics Reports First Quarter Cost Savings, Launches Revenue-generating Initiative | NASDAQ:VVOS

Proactive InvestorsMay 14 12:37 ET

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Might Not Be As Mispriced As It Looks After Plunging 45%

Unfortunately for some shareholders, the Vivos Therapeutics, Inc. (NASDAQ:VVOS) share price has dived 45% in the last thirty days, prolonging recent pain. The recent drop completes a disastrous twe

Simply Wall StApr 26 06:05 ET

Vivos Therapeutics Sees Increased Adoption of Oral Medical Devices From Medicare Reimbursement Approval | NASDAQ:VVOS

Proactive InvestorsApr 11 11:26 ET

Vivos Therapeutics Receives Approval for Medicare Reimbursement for Flagship Oral Medical Devices

Yahoo FinanceApr 9 14:45 ET

What's Going On With Vivos Therapeutics Stock?

Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares are trading lower Tuesday. The company filed a prospectus related to the resale of up to 1.73 million shares of common stock by selling shareholders.The D

BenzingaApr 9 12:36 ET